Your question is Structuring Exclusive Platform Deals. Take a moment with it on the right.
Talk me through your thinking if you like. When you're confident, submit your answer and I'll grade it like a real screen (7/10 or better passes).
If a prospective pharmaceutical partner requests exclusive rights to a broad platform technology, how do you structure the deal to protect our internal pipeline?